查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853843

復健機器人市場按類型、應用和最終用戶分類 - 全球預測 2025-2032

Rehabilitation Robots Market by Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，康復機器人市場規模將達到 16.3419 億美元，複合年成長率為 16.05%。

關鍵市場統計數據
基準年2024年 4.9667億美元
預計年份：2025年 5.7505億美元
預測年份 2032 16.3419億美元
複合年成長率 (%) 16.05%

本文簡要介紹了復健機器人技術的現狀，重點闡述了推動臨床應用的關鍵因素、實行技術擴展的、以患者為中心的解決方案的轉變。

復健機器人技術融合了醫學、工程學和人性化的設計理念，從實驗室原型發展成為可應用於臨床、拓展治療路徑的工具。過去十年間，復健機器人設備已從剛性、工業的機器轉型為更具適應性、感測器更豐富的系統，更加注重患者的舒適度、功能恢復以及數據驅動的個人化治療。這項發展歷程反映了嵌入式感測器、致動器小型化、材料科學以及能夠解讀複雜運動模式的機器主導演算法等領域的同步進步。

臨床醫生和醫療保健系統越來越關注能夠拓展稀缺的復健專業知識、支持強化且可重複的治療療程並客觀評估進展的技術。然而，這些技術的應用受到許多因素的影響，例如能否輕鬆融入臨床工作流程、依證證明其功能改善、報銷機制以及設備的人體工學設計。因此，成功的醫療設備往往將經過驗證的治療通訊協定、直覺的使用者介面和強大的安全功能結合。

該領域未來的發展將取決於從概念驗證到可擴展解決方案的實際轉變，這些解決方案能夠在住院、門診病人和家庭環境中提供可衡量的臨床價值。這一轉變由臨床醫生、工程師和數據科學家之間的多學科合作推動，並由元件供應商、服務合作夥伴和監管機構組成的日益成熟的生態系統的支持。

本文概述了推動復健機器人領域發展的關鍵變革，包括人工智慧整合、醫療服務分散化和穩健的商業化模式。

復健機器人領域正經歷數項變革性轉變，這些轉變正在重塑產品設計、臨床應用模式和商務策略。首先，智慧化已成為主流。內建感測器、雲端分析和自適應控制演算法使設備能夠學習患者獨特的運動模式，並即時調整輔助力度。這種能力有助於更好地實現個人化治療，並為長期療效追蹤創造機會。

其次，醫療服務正從醫院擴展到社區診所和家庭。便攜性、電池技術以及簡化的安裝和拆卸機制的進步，使得臨床醫生和患者能夠在受控實驗室之外使用相關設備。因此，醫療報銷和醫療服務模式也在進行調整，以強調遠距監測、遠距復健支援和基於結果的支付。

第三，人因工程和軟性機器人日益受到關注，設計者不再僅僅追求蠻力驅動，而是更注重舒適性、穿戴性和自然運動輔助。這種關注點有助於減輕患者疲勞，提高依從性，尤其對老年人和神經系統疾病患者而言更是如此。同時，支援軟硬體協同演進的模組化架構也日趨普及，使製造商能夠逐步推出性能改進方案，而無需更換硬體。

最後，供應鏈韌性和監管協調正成為策略要務。製造商正投資於採購多元化、本地組裝和增強上市後監管能力，以滿足嚴格的安全要求並加速臨床應用。這些轉變共同作用，使復健機器人更具臨床相關性、商業性可行性，並可在更廣泛的醫療環境中應用。

2025 年關稅環境如何改變了復健機器人的製造和採購供應鏈、籌資策略和商業模式？

貿易政策和關稅結構的變化可能對復健設備製造商、零件供應商和下游採購商產生重大影響。 2025年美國關稅的累積影響將波及多個業務領域，包括零件採購、製造外包經濟效益和定價策略。依賴進口致動器、精密感測器和特殊聚合物的供應商面臨不斷上漲的投入成本，迫使製造商重新評估其採購佈局和產品架構選擇。

為應對關稅帶來的成本壓力，多家目標商標產品製造商加快了在地化進程，並採取策略性多元化供應商生產過程遷回國內。這些策略有助於降低貿易政策波動帶來的風險，同時維持產品績效。

大型醫療系統內部的採購慣例也發生了變化，採購團隊現在會權衡整體擁有成本、設備效能和支援能力。儘管單位成本面臨上漲壓力，但長期服務協議和多年維護合約作為穩定營運支出的一種方式而受到青睞。同時，一些小型供應商面臨淨利率下降的困境，促使它們進行整合，並重新關注那些差異化技術能夠帶來更大定價權的細分臨床應用領域。

從創新角度來看，關稅限制促使企業重新關注以軟體為中心的提案主張。為了抵​​銷硬體成本上漲帶來的不利影響，企業紛紛轉向雲端分析、遠端醫療模組和訂閱式服務模式。簡而言之，2025 年的關稅環境加速了供應鏈和商業模式的結構性變革，推動了向韌性、模組化和服務主導差異化方向的重新平衡。

深度細分洞察揭示了設備架構、治療用途和最終用戶環境如何決定臨床效用和商業化路徑。

細分市場層面的動態變化闡明了臨床需求、設備功能和護理方式之間的交集，從而影響產品策略和商業化進程。依設備類型分類，可分為末端執行器機器人和外骨骼。末端執行器機器人又可分為固定式（固定在固定平台上）和穿戴式式（支援更自然、以任務為導向的運動）兩種設計路徑，每種設計路徑都會影響臨床工作流程、便攜性和復健任務的針對性。外骨骼則分為全身型、下肢型和上肢型，這些差異導致在驅動複雜性、控制方案和患者穿戴程序等方面需要做出不同的工程權衡。

應用主導的細分突出了老年復健、肌肉骨骼復健、神經復健和中風復健等治療適應症。老年復健設備優先考慮安全性、易用性和防跌倒功能，而肌肉骨骼解決方案則著重於關節層面的輔助和肌肉再訓練。神經科和中風復健專用技術需要更精細的控制、自適應輔助模式和檢驗的療效指標，以支持神經可塑性主導的復健。

終端使用者細分涵蓋了各種部署環境，包括家庭護理、醫院/診所、復健中心和研究機構。居家照護需要簡化的設定、遠端監控和強大的客戶支援。醫院和診所需要與現有治療流程無縫整合，並具備嚴格的感染控制能力。復健中心傾向於選擇能夠支援高強度和專業化通訊協定的設備，而研究機構則優先考慮模組化設計和實驗通訊協定的數據存取。了解設備類型、用途和終端使用者之間的對應關係，對於設計符合臨床路徑和採購標準的、具有商業性可行性的提案至關重要。

深入洞察全球趨勢，包括人口趨勢、醫療保健資金籌措模式和法規環境如何影響全球主要市場的採用軌跡

復健機器人技術的區域發展動態反映了人口壓力、醫療保健資金籌措模式和法規環境的差異。在美洲，人口老化、醫療網路集中化以及完善的報銷體系促進了機器人療法在住院和門診環境中的早期應用。該地區的醫療服務提供者正在評估設備投資在營運效率和長期康復效果方面的價值，而私人支付方和公共項目則對報銷方案的設計產生影響。

歐洲、中東和非洲是一個異質性很強的地區，各國在監管環境、公共醫療支出和臨床實踐模式方面有顯著差異。西方醫療體系通常非常重視實證醫學和成本效益研究，鼓勵採用能展現明確功能優勢的解決方案。相較之下，中東和非洲的一些市場則更注重急診護理，並可能透過卓越中心或私人專科診所引入創新醫療設備，從而形成需求集中的區域。

亞太地區人口結構快速變化，中階醫療保健支出不斷成長，主導大力推動復健基礎設施現代化。該地區多個國家正在投資數位健康平台和居家照護模式，為穿戴式復健設備和遠距醫療服務創造了有利條件。在所有地區，監管協調和國際臨床合作正在為跨境設備核准和多國臨床試驗遠端醫療，加速有效解決方案的全球推廣應用。

深入競爭考察主要企業的策略，揭示臨床證據、軟硬體整合以及服務主導的商業模式如何定義競爭優勢。

復健機器人領域的競爭動態將由那些兼具臨床可靠性、卓越工程技術和靈活市場拓展能力的公司來定義。領先企業正大力投資於臨床證據的積累，與學術醫療中心和復健診所合作，檢驗治療通訊協定並展示功能性療效。這些依證有助於支付方參與，並為衛生經濟學評估提供資訊，而衛生經濟學評估對於醫院採購委員會日益重要。

價值鏈各環節的產品策略各不相同：有些公司優先考慮硬體差異化，例如開發專有的驅動系統、輕質材料和先進的感測套件，而有些公司則專注於實現遠端監控、自適應訓練程序、臨床醫生儀表板等功能的軟體生態系統。越來越多的供應商開始強調可透過軟體升級的互通平台，從而減少頻繁更新硬體的需求，並延長產品生命週期。

商業性成功的公司會將直接臨床銷售與通路夥伴關係以及以服務為導向的收益來源結合。他們還透過培訓計畫、臨床醫生教育和以結果為導向的支持來推動產品應用。與零件供應商、契約製造和復健服務提供者建立策略聯盟，在擴大業務規模和加速地理擴張方面也發揮關鍵作用。總而言之，競爭格局有利於那些能夠證明治療效果、提供無縫臨床整合並持續提供售後支援的機構。

為領導者提供切實可行的建議，以協調產品設計、證據產生和商業策略，從而加速產品推廣並建立具有韌性的企業。

產業領導者可以採取多項切實可行的措施來鞏固其策略地位並加速臨床應用。首先，優先與臨床中心建立夥伴關係，共同製定通訊協定，並產生符合支付方要求的高品質結果數據。循證檢驗不僅對臨床醫生的認可至關重要，而且對報銷談判和採購核准也至關重要。其次，採用模組化產品架構，以實現軟體的迭代改進並允許選擇性地升級硬體。

第三，透過供應商多元化、對二級供應商進行資格認證以及考慮關鍵次組件的本地組裝，投資於供應鏈韌性。這些措施將降低貿易政策和物流風險，同時提高前置作業時間的可預測性。第四，關注終端用戶體驗，設計面向臨床醫生的介面，簡化設備設置，提高佩戴舒適度，並與電子健康記錄整合，從而降低臨床應用門檻，提高患者依從性。

最後，開發一種混合商業模式，將設備銷售與基於訂閱的分析、臨床醫生培訓和遠端監測服務相結合。這種模式能夠產生持續收益，加深客戶關係，並透過持續的績效回饋強化臨床提案主張。這些措施的結合使企業能夠應對複雜的監管環境，適應不斷發展的醫療服務模式，並建立永續的競爭優勢。

採用透明的多方法調查方法，結合專家訪談、技術評估和證據三角驗證，以支持可操作的見解和分析。

本執行摘要的調查方法整合了多方面的證據，以確保提供可靠且可操作的見解。主要研究包括對臨床醫生、復健專業人員、設備工程師和採購專業人員進行結構化訪談，以收集他們對設備可用性、臨床效果和採購標準等方面的現場觀點。除了這些定性資訊外，還對設備架構、控制策略和材料進行了技術評估，以評估工程權衡和整合複雜性。

二次研究檢驗了同行評審的臨床文獻、監管申報文件和公開的技術規範中關於設備性能和治療機制的說法。產業期刊和會議論文集提供了關於試點實施和早期臨床試驗結果的最新資訊。數據綜合強調了資訊來源之間的交叉檢驗以及對證據品質的嚴格評估。

透過透明的三角驗證流程，將定性見解與技術文件和監管資訊結合，從而保持了分析的嚴謹性。研究明確承認了局限性，包括臨床試驗設計的差異和部署環境的異質性。在有證據缺口的情況下，研究者謹慎地提出建議，力求反映一系列可能的結果，而非做出明確的預測。這種調查方法確保結論是基於當前的實踐，並為決策者提供可操作的策略指導。

簡明扼要的結論強調了復健機器人技術的成熟以及將技術進步轉化為持久臨床影響的策略必要性。

在感測器、驅動裝置和智慧控制技術進步的推動下，復健機器人正逐漸發展成為一項具有臨床意義和商業性價值的醫療保健技術。隨著設備變得更加便攜、穿戴式和方便用戶使用，其應用範圍正在住院、門診和家庭環境中不斷擴大。同時，供應鏈的動態變化和不斷變化的報銷機制迫使企業在策略上保持敏捷，並專注於提升韌性和提供以結果為導向的提案主張。

在不斷變化的環境中取得成功，取決於將嚴謹的臨床檢驗、模組化產品設計以及強大的商業支援相結合。那些能夠展現明確治療益處、簡化臨床整合流程並提供以服務主導的經營模式的公司，將更有利於掌握長期市場推廣機會。此外，監管、報銷和醫療服務方面的區域差異也將繼續影響部署重點和整合速度。

總而言之，康復機器人技術正處於一個關鍵時刻，如果相關人員圍繞著證據生成、以患者為中心的設計和永續的商業化策略達成一致，那麼技術能力就可以轉化為有意義的患者療效和新的護理模式。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 利用人工智慧即時監測和自適應輔助技術，制定個人化的復健計劃
  • 開發用於居家上肢運動復健的輕型軟體軟性機器人外骨骼
  • 雲端連結的復健機器人利用巨量資料分析來追蹤和最佳化復健效果。
  • 將虛擬實境環境與機器人平台結合，以提高患者的參與度和積極性。
  • 配備肌電感測器的穿戴式外骨骼，用於為中風患者提供意向驅動的步行輔助
  • 一種模組化機器人系統，專為在各種臨床復健環境中可擴展部署而設計。
  • 觸覺回饋技術的進步可在治療過程中提供更逼真的觸覺和力覺感受。
  • 透過引入遠距復健機器人系統，擴大農村地區遠端醫療的覆蓋範圍。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 康復機器人市場（按類型分類）

  • 末端執行器機器人
    • 固定式
    • 穿戴式裝置
  • 外骨骼機器人
    • 全身
    • 下肢
    • 上肢

第9章 按應用分類的復健機器人市場

  • 老年復健
  • 肌肉骨骼復健
  • 神經復健
  • 中風復健

第10章 依最終用戶分類的復健機器人市場

  • 居家照護
  • 醫院診所
  • 復健中心
  • 研究機構

第11章 各地區復健機器人市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 康復機器人市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國復健機器人市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Hocoma AG
    • Ekso Bionics Holdings, Inc.
    • ReWalk Robotics Ltd.
    • Cyberdyne Inc.
    • Parker-Hannifin Corporation
    • Bionik Laboratories Corp.
    • Bioness, Inc.
    • Fourier Intelligence Group
    • AlterG, Inc.
    • Myomo, Inc.
Product Code: MRR-02026C4CB0B9

The Rehabilitation Robots Market is projected to grow by USD 1,634.19 million at a CAGR of 16.05% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 496.67 million
Estimated Year [2025] USD 575.05 million
Forecast Year [2032] USD 1,634.19 million
CAGR (%) 16.05%

A concise introduction to the present state of rehabilitation robotics highlighting clinical adoption drivers, enabling technologies, and the shift to scalable patient-centered solutions

Rehabilitation robotics is at the intersection of medical science, engineering, and human-centered design, evolving from laboratory prototypes into clinically deployable tools that augment therapeutic pathways. Over the past decade, devices have moved beyond rigid, industrially inspired machines to more adaptive, sensor-rich systems that prioritize patient comfort, functional outcomes, and data-driven therapy personalization. This evolution reflects parallel advances in embedded sensors, actuator miniaturization, materials science, and machine learning algorithms capable of interpreting complex movement patterns.

Clinicians and health systems are increasingly interested in technologies that can extend the reach of scarce rehabilitation expertise, support intensive repeatable therapy sessions, and objectively measure progress. However, adoption is mediated by factors such as ease of integration into clinical workflows, the evidence base demonstrating functional gains, reimbursement frameworks, and device ergonomics. As a result, successful devices combine validated therapeutic protocols with intuitive user interfaces and robust safety features.

Looking ahead, the field is defined by a pragmatic shift: from proof-of-concept demonstrations toward scalable solutions that deliver measurable clinical value across inpatient, outpatient, and home-based settings. This transition is powered by cross-disciplinary collaboration among clinicians, engineers, and data scientists, and is supported by a maturing ecosystem of component suppliers, service partners, and regulatory pathways that together enable responsible clinical deployment.

An overview of the major transformative shifts driving the rehabilitation robotics landscape including AI integration, care decentralization, and resilient commercialization approaches

The rehabilitation robotics landscape is undergoing several transformative shifts that are reshaping product design, clinical use models, and business strategies. First, intelligence infusion is pervasive: embedded sensors, cloud-connected analytics, and adaptive control algorithms now enable devices to learn from patient-specific movement patterns and to modulate assistance in real time. This capability improves therapy personalization and creates opportunities for longitudinal outcome tracking.

Second, the locus of care is expanding beyond hospital walls into community clinics and the home. Advances in portability, battery technology, and simplified donning/dof mechanisms are enabling devices that clinicians and patients can use outside of supervised laboratory settings. Consequently, reimbursement and care-delivery models are adapting to emphasize remote monitoring, tele-rehabilitation support, and outcome-based payment arrangements.

Third, human factors and soft robotics are gaining prominence, with designers focusing on comfort, wearability, and naturalistic movement assistance rather than brute-force actuation. This emphasis reduces patient fatigue and improves adherence, particularly among geriatric and neurologic populations. In parallel, modular architectures that support hardware-software co-evolution are becoming common, allowing manufacturers to deploy iterative performance improvements without wholesale hardware replacement.

Finally, supply chain resilience and regulatory alignment are emerging as strategic imperatives. Manufacturers are investing in diversified sourcing, localized assembly, and stronger post-market surveillance capabilities to meet stringent safety expectations and to shorten time-to-clinical-deployment. Collectively, these shifts are converging to make rehabilitation robots more clinically relevant, commercially viable, and accessible across a broader range of care settings.

How the 2025 tariff environment reshaped supply chains, sourcing strategies, and commercial models for rehabilitation robotics across manufacturing and procurement

Changes in trade policy and tariff structures can materially affect manufacturers, component suppliers, and downstream purchasers of rehabilitation devices. The cumulative impact of United States tariffs enacted in 2025 has manifested across multiple operational vectors, including component sourcing, contract manufacturing economics, and pricing strategies. Suppliers reliant on imported actuators, precision sensors, or specialized polymers have faced increased input costs, which in turn pressured manufacturers to reassess sourcing footprints and product architecture choices.

In response to tariff-driven cost pressures, several original equipment manufacturers accelerated localization initiatives and strategic supplier diversification to mitigate exposure. These adjustments have included qualifying alternative vendors, redesigning assemblies to use more readily available components, and selectively onshoring higher-value production steps where labor and capital economics permitted. Such strategies helped preserve product performance while reducing vulnerability to trade policy volatility.

Procurement practices among large healthcare systems also shifted, as purchasing teams weighed total cost of ownership against device performance and support capabilities. Longer-term service agreements and multi-year maintenance contracts gained traction as ways to stabilize operating expenses despite unit price pressures. At the same time, some small and mid-sized suppliers encountered tighter margins, prompting consolidation activity and renewed focus on niche clinical applications where differentiated technology commands stronger pricing power.

From an innovation perspective, tariff-induced constraints spurred renewed emphasis on software-centric value propositions. Companies leaned into cloud analytics, remote therapy modules, and subscription-based service models to offset hardware cost headwinds. In short, the 2025 tariff environment accelerated structural changes in supply chains and commercial models, prompting a rebalancing toward resilience, modularity, and service-led differentiation.

Deep segmentation insights revealing how device architecture, therapeutic application, and end-user settings jointly determine clinical utility and commercialization pathways

Segment-level dynamics underscore where clinical need, device capability, and care delivery intersect to shape product strategy and commercialization. Based on device type, the universe includes End Effector Robots and Exoskeleton Robots. End Effector Robots are differentiated by stationary designs that anchor to a fixed platform and wearable variants that enable more natural, task-oriented exercises; each design path influences clinical workflows, portability, and rehabilitation task specificity. Exoskeleton Robots split into Full Body, Lower Limb, and Upper Limb categories, and these distinctions drive divergent engineering trade-offs in actuation complexity, control schemes, and patient fitting procedures.

Application-driven segmentation highlights therapeutic indications such as Geriatric Rehabilitation, Musculoskeletal Rehabilitation, Neurological Rehabilitation, and Stroke Rehabilitation. Devices tailored for geriatric rehabilitation prioritize safety, ease of use, and fall-mitigation features, while musculoskeletal solutions emphasize joint-level assistance and strength retraining. Neurological and stroke-focused technologies demand finer-grained control, adaptive assistance profiles, and validated outcome measures to support neuroplasticity-driven recovery.

End-user segmentation captures the diversity of deployment environments, spanning Home Care, Hospitals and Clinics, Rehabilitation Centers, and Research Institutes. Home care deployments require simplified setup, remote monitoring, and robust customer support. Hospitals and clinics demand seamless integration with existing therapy workflows and stringent infection control features. Rehabilitation centers favor devices that enable high-intensity, specialized protocols, and research institutes prioritize modularity and data access for experimental protocols. Understanding how device types map to applications and end users is essential for designing commercially viable propositions that align with clinical pathways and procurement norms.

Key regional insights into how demographic trends, healthcare funding models, and regulatory environments shape adoption trajectories across major global markets

Regional dynamics for rehabilitation robotics reflect differing demographic pressures, healthcare financing models, and regulatory environments. In the Americas, aging populations, concentrated healthcare networks, and established reimbursement systems have supported early adoption of both inpatient and outpatient robotic therapies. Healthcare providers in this region increasingly evaluate device investments against operational efficiencies and long-term rehabilitative outcomes, while private payers and public programs influence reimbursement design.

Europe, Middle East & Africa present a heterogeneous landscape where national regulatory frameworks, public healthcare funding, and clinical practice patterns vary widely. Western European health systems often emphasize evidence generation and cost-effectiveness studies, encouraging solutions that demonstrate clear functional gains. Meanwhile, some Middle Eastern and African markets prioritize acute care capabilities and may adopt innovative devices through centers of excellence or private specialty clinics, creating pockets of concentrated demand.

Asia-Pacific is characterized by rapid demographic shifts, expanding middle-class healthcare consumption, and strong government-led initiatives to modernize rehabilitation infrastructure. Several countries in the region are investing in digital health platforms and home-based care models, which create fertile conditions for wearable rehabilitation devices and remote therapy services. Across all regions, regulatory harmonization efforts and international clinical collaborations are smoothing pathways for cross-border device approval and multinational clinical trials, thereby accelerating global diffusion of validated solutions.

Insightful analysis of company strategies showing how clinical evidence, hardware-software integration, and service-led commercial models define competitive advantage

Competitive dynamics in rehabilitation robotics are defined by firms that combine clinical credibility with engineering excellence and go-to-market agility. Leading organizations invest heavily in clinical evidence generation, partnering with academic medical centers and rehabilitation clinics to validate therapeutic protocols and demonstrate functional outcomes. This evidence base supports engagement with payers and informs health economic assessments that are increasingly essential for hospital procurement committees.

Product strategies vary across the value chain. Some companies prioritize hardware differentiation-developing proprietary actuation systems, lightweight materials, and advanced sensing suites-while others focus on software ecosystems that enable remote monitoring, adaptive training programs, and clinician dashboards. A growing number of vendors emphasize interoperable platforms that can be upgraded via software, reducing the need for frequent hardware revisions and extending product lifecycles.

Commercially, successful firms blend direct clinical sales with channel partnerships and service-oriented revenue streams. They bolster adoption through training programs, clinician education, and outcomes-driven support offerings. Strategic alliances with component suppliers, contract manufacturers, and rehabilitation service providers also play an important role in scaling operations and accelerating geographic expansion. Overall, the competitive landscape rewards organizations that can demonstrate therapeutic benefit, deliver seamless clinical integration, and sustain post-sale support.

Actionable recommendations for leaders to align product design, evidence generation, and commercial strategies to accelerate adoption and build resilient operations

Industry leaders can take several practical actions to strengthen their strategic position and accelerate adoption across care settings. First, prioritize partnerships with clinical centers to co-develop protocols and generate high-quality outcome data that align with payer requirements. Evidence-based validation is critical not only for clinician acceptance but also for reimbursement discussions and procurement approvals. Second, pursue modular product architectures that enable iterative software improvements and allow selective hardware upgrades; this reduces total cost of ownership concerns and supports longer customer relationships.

Third, invest in supply-chain resilience by diversifying suppliers, qualifying secondary vendors, and considering localized assembly for critical subassemblies. Such measures mitigate trade-policy and logistics risks while improving lead-time predictability. Fourth, focus on the end-user experience-simplifying device setup, enhancing wearability, and designing clinician-facing interfaces that integrate with electronic health records-to lower barriers to clinical adoption and increase patient adherence.

Finally, develop hybrid commercial models that combine device sales with subscription-based services for analytics, clinician training, and remote monitoring. This approach creates recurring revenue, deepens customer relationships, and reinforces the clinical value proposition through continuous performance feedback. Taken together, these actions can help organizations navigate regulatory complexity, align with evolving care delivery models, and build sustainable competitive differentiation.

A transparent multi-method research methodology combining expert interviews, technical assessments, and evidence triangulation to underpin actionable insights and analysis

The research methodology underpinning this executive summary integrates multiple evidence streams to ensure robust, actionable insights. Primary research included structured interviews with clinicians, rehabilitation specialists, device engineers, and procurement professionals to capture frontline perspectives on usability, clinical outcomes, and purchasing criteria. These qualitative inputs were complemented by technical assessments of device architectures, control strategies, and materials to evaluate engineering trade-offs and integration complexity.

Secondary research drew on peer-reviewed clinical literature, regulatory filings, and publicly available technical specifications to triangulate claims about device performance and therapeutic mechanisms. Trade publications and conference proceedings provided contemporary examples of pilot deployments and early-stage clinical results. Data synthesis emphasized cross-validation among sources and critical appraisal of evidence quality.

Analytical rigor was maintained through a transparent triangulation process that reconciled qualitative insights with technical documentation and regulatory information. Limitations were explicitly acknowledged, including variability in clinical study designs and heterogeneity in deployment contexts. Where evidence gaps existed, recommendations were cautiously framed to reflect the range of plausible outcomes rather than definitive forecasts. This methodology ensures that conclusions are grounded in current practice and that strategic guidance remains practical for decision-makers.

A concise conclusion emphasizing the maturation of rehabilitation robotics and the strategic imperatives for translating technological advances into sustained clinical impact

Rehabilitation robotics is maturing into a clinically relevant and commercially viable segment of healthcare technology, driven by converging advances in sensors, actuation, and intelligent control. Adoption is expanding across inpatient, outpatient, and home settings as devices become more portable, wearable, and user-friendly. At the same time, supply-chain dynamics and evolving reimbursement frameworks require companies to be strategically nimble, emphasizing resilience and outcome-oriented value propositions.

Success in this evolving landscape depends on combining rigorous clinical validation with modular product design and robust commercial support. Firms that demonstrate clear therapeutic benefits, simplify clinical integration, and offer service-led business models will be well positioned to capture long-term adoption opportunities. Additionally, regional nuances in regulation, reimbursement, and care delivery will continue to influence deployment priorities and the pace of integration.

In sum, rehabilitation robotics stands at a pivotal moment where technological capability can translate into meaningful patient outcomes and new care paradigms, provided that stakeholders align around evidence generation, patient-centric design, and sustainable commercialization strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. AI-driven real-time monitoring and adaptive assistance for personalized rehabilitation regimens
  • 5.2. Development of lightweight soft robotic exosuits for home-based upper limb motor recovery training
  • 5.3. Cloud-connected rehabilitation robots leveraging big data analytics for outcome tracking and optimization
  • 5.4. Integration of virtual reality environments with robotic platforms to enhance patient engagement and motivation
  • 5.5. Wearable exoskeletons equipped with EMG sensors for intention-driven gait assistance in stroke survivors
  • 5.6. Modular robotic systems designed for scalable deployment across diverse clinical rehabilitation settings
  • 5.7. Advancements in haptic feedback technologies enabling more realistic touch and force sensations during therapy
  • 5.8. Implementation of tele-rehabilitation robotic systems to expand remote therapy access in rural communities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Rehabilitation Robots Market, by Type

  • 8.1. End Effector Robots
    • 8.1.1. Stationary
    • 8.1.2. Wearable
  • 8.2. Exoskeleton Robots
    • 8.2.1. Full Body
    • 8.2.2. Lower Limb
    • 8.2.3. Upper Limb

9. Rehabilitation Robots Market, by Application

  • 9.1. Geriatric Rehabilitation
  • 9.2. Musculoskeletal Rehabilitation
  • 9.3. Neurological Rehabilitation
  • 9.4. Stroke Rehabilitation

10. Rehabilitation Robots Market, by End User

  • 10.1. Home Care
  • 10.2. Hospitals Clinics
  • 10.3. Rehabilitation Centers
  • 10.4. Research Institutes

11. Rehabilitation Robots Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Rehabilitation Robots Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Rehabilitation Robots Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Hocoma AG
    • 14.3.2. Ekso Bionics Holdings, Inc.
    • 14.3.3. ReWalk Robotics Ltd.
    • 14.3.4. Cyberdyne Inc.
    • 14.3.5. Parker-Hannifin Corporation
    • 14.3.6. Bionik Laboratories Corp.
    • 14.3.7. Bioness, Inc.
    • 14.3.8. Fourier Intelligence Group
    • 14.3.9. AlterG, Inc.
    • 14.3.10. Myomo, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. REHABILITATION ROBOTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. REHABILITATION ROBOTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. REHABILITATION ROBOTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL REHABILITATION ROBOTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL REHABILITATION ROBOTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WEARABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WEARABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WEARABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WEARABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. GCC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GCC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GCC REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. GCC REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. GCC REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 222. GCC REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 223. GCC REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 224. GCC REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 225. GCC REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. GCC REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. GCC REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. GCC REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 247. BRICS REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 248. BRICS REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 249. BRICS REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. BRICS REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. BRICS REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. BRICS REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. G7 REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. G7 REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. G7 REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. G7 REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. G7 REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 258. G7 REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 259. G7 REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 260. G7 REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 261. G7 REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. G7 REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. G7 REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. G7 REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. NATO REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NATO REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NATO REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NATO REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NATO REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 270. NATO REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 271. NATO REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 272. NATO REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 273. NATO REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. NATO REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. NATO REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. NATO REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 283. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 285. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 293. CANADA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 294. CANADA REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 295. CANADA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. CANADA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. CANADA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. CANADA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 303. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 304. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 305. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. MEXICO REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 312. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 313. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 314. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 315. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. BRAZIL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY END EFFECTOR ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, 2025-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED KINGDOM REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. GERMANY REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. GERMANY REHABILITATION ROBOTS MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)

TABLE